DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
$356.32 -12.38 (-3.36%)
As of 03/04/2021 15:59:55 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.